Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Robertson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|April 6, 2023
Point estimation for adaptive trial designs II: Practical considerations and guidanceDavid S Robertson, Babak Choodari-Oskooei, Munya Dimairo, et al.
Statistics in Medicine|November 30, 2022
Point estimation for adaptive trial designs I: A methodological reviewDavid S Robertson, Babak Choodari-Oskooei, Munya Dimairo, et al.
Statistical Methods in Medical Research|January 19, 2026
A burn-in(g) question: How long should an initial equal randomization stage be before Bayesian response-adaptive randomization?Edwin Yn Tang, Stef Baas, Daniel Kaddaj, et al.
Statistics in Medicine|August 8, 2025
Confidence Intervals for Adaptive Trial Designs I: A Methodological ReviewDavid S Robertson, Thomas Burnett, Babak Choodari-Oskooei, et al.
BMC Infectious Diseases|December 22, 2023
Evaluating pooled testing for asymptomatic screening of healthcare workers in hospitalsBethany Heath, Stephanie Evans, David S Robertson, et al.
Statistics in Medicine|August 9, 2025
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical GuidanceDavid S Robertson, Thomas Burnett, Babak Choodari-Oskooei, et al.
The American Statistician|January 7, 2022
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory TrialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
Statistics in Medicine|January 13, 2022
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
Transplantation and Cellular Therapy|November 9, 2025
Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host DiseaseDaniel Wolff, Corey Cutler, Iveta Mercep, et al.
Statistics in Medicine|March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation PrinciplesKim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|April 6, 2023
Point estimation for adaptive trial designs II: Practical considerations and guidanceDavid S Robertson, Babak Choodari-Oskooei, Munya Dimairo, et al.
Statistics in Medicine|November 30, 2022
Point estimation for adaptive trial designs I: A methodological reviewDavid S Robertson, Babak Choodari-Oskooei, Munya Dimairo, et al.
Statistical Methods in Medical Research|January 19, 2026
A burn-in(g) question: How long should an initial equal randomization stage be before Bayesian response-adaptive randomization?Edwin Yn Tang, Stef Baas, Daniel Kaddaj, et al.
Statistics in Medicine|August 8, 2025
Confidence Intervals for Adaptive Trial Designs I: A Methodological ReviewDavid S Robertson, Thomas Burnett, Babak Choodari-Oskooei, et al.
BMC Infectious Diseases|December 22, 2023
Evaluating pooled testing for asymptomatic screening of healthcare workers in hospitalsBethany Heath, Stephanie Evans, David S Robertson, et al.
Statistics in Medicine|August 9, 2025
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical GuidanceDavid S Robertson, Thomas Burnett, Babak Choodari-Oskooei, et al.
The American Statistician|January 7, 2022
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory TrialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
Statistics in Medicine|January 13, 2022
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trialsKevin Kunzmann, Michael J Grayling, Kim May Lee, et al.
Transplantation and Cellular Therapy|November 9, 2025
Toward Better and More Effective Clinical Trials for Chronic Graft-Versus-Host DiseaseDaniel Wolff, Corey Cutler, Iveta Mercep, et al.
Statistics in Medicine|March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation PrinciplesKim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
Pageof 4